FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005479110> ?p ?o ?g. }

• W2005479110 endingPage "5982" @default.
• W2005479110 startingPage "5972" @default.
• W2005479110 abstract "Abstract Because primary myelofibrosis (PMF) originates at the level of the pluripotent hematopoietic stem cell (HSC), we examined the effects of various therapeutic agents on the in vitro and in vivo behavior of PMF CD34+ cells. Treatment of PMF CD34+ cells with chromatin-modifying agents (CMAs) but not hydroxyurea, Janus kinase 2 (JAK2) inhibitors, or low doses of interferon-α led to the generation of greater numbers of CD34+ chemokine (C-X-C motif) receptor (CXCR)4+ cells, which were capable of migrating in response to chemokine (C-X-C motif) ligand (CXCL)12 and resulted in a reduction in the proportion of hematopoietic progenitor cells (HPCs) that were JAK2V617F+. Furthermore, sequential treatment of PMF CD34+ cells but not normal CD34+ cells with decitabine (5-aza-2′-deoxycytidine [5azaD]), followed by suberoylanilide hydroxamic acid (SAHA; 5azaD/SAHA), or trichostatin A (5azaD/TSA) resulted in a higher degree of apoptosis. Two to 6 months after the transplantation of CMAs treated JAK2V617F+ PMF CD34+ cells into nonobese diabetic/severe combined immunodeficient (SCID)/IL-2Rγnull mice, the percentage of JAK2V617F/JAK2total in human CD45+ marrow cells was dramatically reduced. These findings suggest that both PMF HPCs, short-term and long-term SCID repopulating cells (SRCs), are JAK2V617F+ and that JAK2V617F+ HPCs and SRCs can be eliminated by sequential treatment with CMAs. Sequential treatment with CMAs, therefore, represents a possible effective means of treating PMF at the level of the malignant SRC." @default.
• W2005479110 created "2016-06-24" @default.
• W2005479110 creator A5006372952 @default.
• W2005479110 creator A5014205411 @default.
• W2005479110 creator A5014578404 @default.
• W2005479110 creator A5033704013 @default.
• W2005479110 creator A5042829932 @default.
• W2005479110 creator A5051151707 @default.
• W2005479110 creator A5087099599 @default.
• W2005479110 creator A5087689514 @default.
• W2005479110 date "2010-12-23" @default.
• W2005479110 modified "2023-10-01" @default.
• W2005479110 title "Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells" @default.
• W2005479110 cites W1504115723 @default.
• W2005479110 cites W1978892900 @default.
• W2005479110 cites W1988879621 @default.
• W2005479110 cites W1992039743 @default.
• W2005479110 cites W1996502308 @default.
• W2005479110 cites W2005852731 @default.
• W2005479110 cites W2021902166 @default.
• W2005479110 cites W2028803880 @default.
• W2005479110 cites W2030358773 @default.
• W2005479110 cites W2042473102 @default.
• W2005479110 cites W2045542032 @default.
• W2005479110 cites W2046160400 @default.
• W2005479110 cites W2048394134 @default.
• W2005479110 cites W2059251144 @default.
• W2005479110 cites W2071115015 @default.
• W2005479110 cites W2072808238 @default.
• W2005479110 cites W2076709820 @default.
• W2005479110 cites W2098971500 @default.
• W2005479110 cites W2106609638 @default.
• W2005479110 cites W2108664872 @default.
• W2005479110 cites W2116878961 @default.
• W2005479110 cites W2119629439 @default.
• W2005479110 cites W2137437637 @default.
• W2005479110 cites W2140204965 @default.
• W2005479110 cites W2140513457 @default.
• W2005479110 cites W2149379768 @default.
• W2005479110 cites W2156318711 @default.
• W2005479110 cites W2327579133 @default.
• W2005479110 cites W34668368 @default.
• W2005479110 doi "https://doi.org/10.1182/blood-2010-02-269696" @default.
• W2005479110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3031385" @default.
• W2005479110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20858855" @default.
• W2005479110 hasPublicationYear "2010" @default.
• W2005479110 type Work @default.
• W2005479110 sameAs 2005479110 @default.
• W2005479110 citedByCount "29" @default.
• W2005479110 countsByYear W20054791102012 @default.
• W2005479110 countsByYear W20054791102013 @default.
• W2005479110 countsByYear W20054791102014 @default.
• W2005479110 countsByYear W20054791102015 @default.
• W2005479110 countsByYear W20054791102016 @default.
• W2005479110 countsByYear W20054791102017 @default.
• W2005479110 countsByYear W20054791102018 @default.
• W2005479110 countsByYear W20054791102021 @default.
• W2005479110 crossrefType "journal-article" @default.
• W2005479110 hasAuthorship W2005479110A5006372952 @default.
• W2005479110 hasAuthorship W2005479110A5014205411 @default.
• W2005479110 hasAuthorship W2005479110A5014578404 @default.
• W2005479110 hasAuthorship W2005479110A5033704013 @default.
• W2005479110 hasAuthorship W2005479110A5042829932 @default.
• W2005479110 hasAuthorship W2005479110A5051151707 @default.
• W2005479110 hasAuthorship W2005479110A5087099599 @default.
• W2005479110 hasAuthorship W2005479110A5087689514 @default.
• W2005479110 hasBestOaLocation W20054791101 @default.
• W2005479110 hasConcept C10205521 @default.
• W2005479110 hasConcept C104317684 @default.
• W2005479110 hasConcept C109159458 @default.
• W2005479110 hasConcept C150194340 @default.
• W2005479110 hasConcept C150903083 @default.
• W2005479110 hasConcept C153911025 @default.
• W2005479110 hasConcept C190727270 @default.
• W2005479110 hasConcept C201750760 @default.
• W2005479110 hasConcept C203014093 @default.
• W2005479110 hasConcept C207001950 @default.
• W2005479110 hasConcept C2776090121 @default.
• W2005479110 hasConcept C2777865847 @default.
• W2005479110 hasConcept C2778305200 @default.
• W2005479110 hasConcept C2779468541 @default.
• W2005479110 hasConcept C2780007613 @default.
• W2005479110 hasConcept C2780235182 @default.
• W2005479110 hasConcept C28328180 @default.
• W2005479110 hasConcept C2908885563 @default.
• W2005479110 hasConcept C502942594 @default.
• W2005479110 hasConcept C55493867 @default.
• W2005479110 hasConcept C64927066 @default.
• W2005479110 hasConcept C86803240 @default.
• W2005479110 hasConcept C8891405 @default.
• W2005479110 hasConcept C95444343 @default.
• W2005479110 hasConceptScore W2005479110C10205521 @default.
• W2005479110 hasConceptScore W2005479110C104317684 @default.
• W2005479110 hasConceptScore W2005479110C109159458 @default.
• W2005479110 hasConceptScore W2005479110C150194340 @default.
• W2005479110 hasConceptScore W2005479110C150903083 @default.
• W2005479110 hasConceptScore W2005479110C153911025 @default.
• W2005479110 hasConceptScore W2005479110C190727270 @default.

• next